Speakers

Speakers Include:

• Naír Rodríguez-Hornedo, PhD, Associate Professor of Pharmaceutical Sciences, The College of Pharmacy, The University of Michigan
• Harry G. Brittain, PhD, FRSC, Institute Director, Center for Pharmaceutical Physics
• René Holm, PhD, Head, Preformulation, H. Lundbeck Denmark
• M. Sherry Ku, PhD, Senior Director, Pharmaceutical Development, Pfizer, Inc.
• Robin H. Bogner PhD, Associate Professor of Pharmaceutics, School of Pharmacy, University of Connecticut
• Satej Bhandarkar, PhD, Senior Manager, Analytical Sciences Department, Sanofi-Aventis U.S.
• Jaymin Shah, PhD, Research Fellow, Parenteral Development Centre of Emphasis, Pfizer, Inc.
• Yun Alelyunas, PhD, Principal, Scientist I, Head of Physical Properties Team, AstraZeneca
• Feng Qian, PhD, Senior Research Investigator, Bristol-Myers Squibb
• Xiaoming (Sean) Chen, PhD, Drug Product Development & Manufacturing, OSI Pharmaceuticals, Inc.
• Vivian Bi, PhD, Associate Principle Scientist, Early Development, PAR&D, AstraZeneca
• Yaling Wang, PhD, Research Fellow, Merck & Co.
• Jeffrey Skell, PhD, Director, DMPK & Pharmaceutics, Drug and Biomaterial R & D, Genzyme Corporation
• Ron Liu, PhD MBA, President & Chief Executive Officer, AustarPharma
• Michael Pikal, PhD, Professor and Pfizer Distinguished, Chair, Pharmaceutical Technology, University of Connecticut
• Peter Karpinski, PhD, US Leader of Salt & Polymorphism and Particle Engineering, Networks, Novartis Pharmaceuticals Corp
• Reza Fassihi, Ph.D, AAPS Fellow, Professor of Biopharmaceutics and Industrial Pharmacy, Temple University
• Chong-Hui Gu, PhD, Associate Director, Pharmaceutical Development, Vertex Pharmaceuticals
• Ian Buxton, PhD, Director, Product Development, WW Pharmaceutical Development, GlaxoSmithKline
• Narayan Variankaval, PhD, Research Fellow, Merck Research Laboratories
• Navnit H. Shah, PhD, Distinguished Research Leader, Pharmaceutical R&D, Hoffmann-La Roche Inc.
• Duk Soon Choi, PhD, Research Leader, Hoffmann La Roche
• Manuel V. Sanchez, PhD, Research Advisor, Eli Lilly and Company
• Suma Gopinathan, MSc, Associate Scientist and Head of Discovery Formulation, Lexicon Pharmaceuticals
• Troy Harmon, Vice President, Business Development, Eurand
• David Lyon, PhD, Vice President, Physical and Biological Sciences, Bend, Research, Inc.
• Jeff Browne, PhD, Director, Technical Support, Business Development, Catalent Pharma Solutions
• René Holm, PhD, Head, Preformulation, H. Lundbeck Denmark
• James D. Pipkin, PhD, Senior Director, New Product Development, CyDex Pharmaceuticals

[ Register Now ]